NCT01861249View on ClinicalTrials.gov

Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

April 30, 2016

Conditions
Ulcerative Colitis
Interventions
DRUG

SAR339658

"Pharmaceutical form: Solution for infusion~Route of administration: Intravenous"

Trial Locations (5)

32789

Investigational Site Number 840048, Winter Park

33025

Investigational Site Number 840008, Miramar

65265

Investigational Site Number 840024, Mexico

78229

Investigational Site Number 840088, San Antonio

91345

Investigational Site Number 840059, Mission Hills

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT01861249 - Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC) | Biotech Hunter | Biotech Hunter